Dr. Jonathan Andrew Beilan, MD

Dr. Beilan practices at Advanced Urology Institute in Oxford, Florida.

Dr. Beilan's NPI, 1528300712, was assigned on March 26, 2013. Dr. Beilan graduated from University of Central Florida College of Medicine in 2013. Dr. Beilan holds Florida license ME141409.

Dr. Beilan's primary practice is Advanced Urology Institute, at 12109 County Rd 103, Oxford, FL 34484 in Sumter County. The practice phone is (352) 391-6494.

Dr. Beilan's primary practice is Advanced Urology Institute in Oxford, Florida. Dr. Beilan is also affiliated with Morton Plant Hospital. The medical group on file is Advanced Urology Institute. Dmand AI also links Dr. Beilan to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beilan practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Beilan's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Beilan is board certified in urology by the American Board of Urology. Dr. Beilan is licensed in Florida.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and testicular dysfunction among the conditions Dr. Beilan treats.

CMS data shows 1,886 Medicare services from Dr. Beilan across 23 procedure codes in 2024, for 459 Medicare patients. Medicare paid $108,166 for them.

CMS counts 459 Medicare patients who saw Dr. Beilan in 2024. The largest group is 65 to 74, with 220 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beilan's median patient age at 61, with 7% women.

In 2024, Dr. Beilan wrote 1,428 Medicare Part D claims for 416 patients. 92% of them were for generic drugs. CMS names the drug for 1,267 of them, across 20 drugs with 11 or more claims each, at $97,577 in total drug cost. In 2023, CMS named 1,310 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Beilan for performance year 2024, reported as part of a group. Dr. Beilan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beilan as offering telehealth.

Dmand AI links 20 papers to Dr. Beilan, published from 2013 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Penile Implantation, Erectile Dysfunction and Penile Prosthesis. Dr. Beilan has published most often in J Sex Med. Dr. Beilan's most frequent co-authors are Rafael E. Carrion, MD, Adam Seth Baumgarten, MD and Larry I. Lipshultz, MD.

CMS Open Payments shows 790 general payments to Dr. Beilan from 48 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Boston Scientific Corporation paid the most, $100,531.

Dr. Beilan graduated from University of Central Florida College of Medicine in 2013.

Dr. Beilan is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.